Back

Comparative safety and effectiveness of vitamin K antagonist and direct oral anticoagulants in patients with atrial fibrillation undergoing transcatheter aortic valve implantation

31 August 2019 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Transcatheter aortic interventions Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Jawad Haider Butt

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

8 More presentations in this session

Presentation thumbnail
Doctor P. Stachon (Freiburg, DE)
Abstract Slides
Presentation thumbnail
Doctor L. Fusini (Milan, IT)
Abstract
Presentation thumbnail
Doctor R. Kuperstein (Ramat Gan, IL)
Abstract
Presentation thumbnail
Mr M. Lemes (Sao Paulo, BR)
Abstract Slides
Presentation thumbnail
Doctor J. Hoffmann (Frankfurt, DE)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Transcatheter aortic interventions

The Event

Event poster

ESC Congress 2019

31 August 2019 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Meta-analysis on the comparison of direct oral anticoagulants versus vitamin k antagonists after transcatheter aortic valve implantation in patients with pre-existing atrial fibrillation
26 August 2022
thumbnail
Congress Presentation
Comparing machine learning models with established risk scores in predicting bleeding and ischaemic stroke in patients with atrial fibrillation undergoing transcatheter aortic valve implantation
31 August 2025
thumbnail
Congress Presentation
Direct oral anticoagulants, all-cause mortality and cardiovascular events in patients with atrial fibrillation with and without obesity: a sub-analysis of the nationwide START registry.
1 September 2025
thumbnail
Congress Presentation
Oral anticoagulation in 13,344 adult patients with congenital heart disease (ACHD) in a longitudinal real-world setting in 2005-2017
2 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources